Tokushima Y, Tago M, Tokushima M, et al. Int J Gen Med. 2020;13:743—750.
The authors have advised there are errors in Table 1 on page 746 in the Hbs-Ag positive patients’ data. The errors were introduced during the creation of the Table.
Table 1.
Characteristics of Hepatitis B Surface Antigen-Positive Patients and with Moderate to High Titers of Hepatitis C Virus Antibodies
| HBs-Ag-Positive | Moderate to High HCV-Ab Titers | |||
|---|---|---|---|---|
| Age (years) | 62.1 | ± 17.7 | 69.3 | ± 15.4 |
| Male sex | 36 | 43.9% | 142 | 50.9% |
| Internal medicine department | 16 | 19.5% | 60 | 21.5% |
| PLT (×104/μL) | 20.0 | ± 7.7 | 17.2 | ± 6.9 |
| AST (U/L) | 55.5 | ± 221.9 | 36.8 | ± 40.4 |
| ALT (U/L) | 67.6 | ± 366.5 | 26.2 | ± 23.4 |
| γ-GTP (U/L) | 34.8 | ± 33.8 | 36.9 | ± 42.2 |
| HBs-Ag (IU/mL) | 3967.2 | ± 12371.6 | - | - |
| HCV-Ab (S/CO) | - | - | 12.8 | ± 3.8 |
| Referred group | 29 | 35.4% | 33 | 11.8% |
Notes: Nominal variables are expressed as numbers and percentages, continuous variables are expressed as mean and standard deviation.Abbreviations: PLT, platelet count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; HBs-Ag, hepatitis B surface antigen; HCV-Ab, hepatitis C virus antibody.
The correct Table 1 is shown below:
The errors were only in the patients’ background and do not affect the main results (consultation rate, comparison of RF and non-RF groups), discussion, or conclusion of the paper.
The authors apologize for these errors.